alab: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Revenue	581,942	351,367	159,442	-
Cost of revenue	141,156	86,393	40,031	-
Stock-based compensation	117,965	77,605	42,484	-
Personnel-related expenses	139,174	86,282	42,439	-
Other segment items	9,495	18,049	2,669	-
Net income (loss)	174,152	83,038	31,819	-108,134
Stock-based compensation	118,659	77,920	42,446	186,370
Inventory write-downs	-	-	-	951
Depreciation	-	-	-	2,180
Depreciation and amortization	3,983	2,517	1,125	-
Non-cash operating lease expense	2,290	1,522	696	1,687
Warrants contra revenue	4,016	2,136	374	946
Accretion of discounts on marketable securities	6,278	4,489	2,542	4,868
Other, net	-231	-734	1,025	-
Accounts receivable, net	4,089	-14,491	30,968	17,054
Inventory	7,106	14,577	6,787	1,271
Prepaid expenses and other assets	56,760	18,474	14,495	4,998
Accounts payable	-1,088	4,607	2,226	11,723
Accrued expenses and other liabilities	-624	-1,592	-11,676	31,094
Operating lease liability	-3,345	-1,963	-689	-1,653
Net cash provided by operating activities	224,041	145,870	10,504	96,973
Purchases of property and equipment	18,855	6,562	4,539	18,797
Purchases of marketable securities	664,432	404,682	190,821	724,921
Maturities of marketable securities	-	-	-	36,579
Sales and maturities of marketable securities	515,109	343,611	191,420	-
Sales of marketable securities	-	-	-	40,998
Other investing activities	500	-	-	-
Net cash used in investing activities	-168,678	-67,633	-3,940	-666,141
Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and commissions	0	0	0	672,198
Payment of deferred offering costs	0	0	0	4,801
Tax withholding related to net share settlements of restricted stock units	0	0	0	20,111
Proceeds from exercises of stock options, net of repurchases	1,730	778	386	2,901
Proceeds from employee stock purchase plan	4,345	4,345	-	-
Net cash provided by financing activities	6,075	5,123	386	650,187
Net increase in cash, cash equivalents, and restricted cash	61,438	83,360	6,950	81,019
Cash and cash equivalents at beginning of period	80,044	80,044	80,044	45,098
Cash and cash equivalents at end of period	141,482	163,404	86,994	126,117

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

alab: the cashflow